Sort
21,281 grants matching “influenza”
Monitoring the Aging Lung Through Proteomics and Quantum Imaging
$543,863William Edward Balch · Northwestern University At Chicago · P01 · FY2018 · AG
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$543,651Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2022 · AI
Scaling and Sustaining COVID-19 Vaccination through Meaningful Community Engagement and Care Coordination for Underserved Communities
$543,599Nicole A Stadnick · University Of California, San Diego · R01 · FY2024 · MD
Role of alterations in the ATII cell lipidome in influenza pathogenesis
$543,563Ian Christopher Davis · Ohio State University · R01 · FY2018 · HL
Coordinated regeneration of lung epithelial and endothelial compartments
$543,560Andrew Vaughan · University Of Pennsylvania · R01 · FY2024 · HL
The B Cell Insulin Receptor in Health and in Insulin Resistance
$543,472Dan Winer · Buck Institute For Research On Aging · R01 · FY2024 · DK
Innate-like BCR activity as a template for universal vaccination against influenza virus
$543,444Daniel Lingwood · Massachusetts General Hospital · R01 · FY2019 · AI
Factors Influencing Pediatric Asthma into Adulthood (FIPA2)
$543,377Lyle G Best · Missouri Breaks Research, Inc. · R01 · FY2025 · MD
Project 1: Costimulation and Regulation of Anti-viral Immunity
$543,308Arlene H Sharpe · Harvard Medical School · P01 · FY2018 · AI
Mindfulness based stress reduction for family caregivers of dementia patients
$543,277Jan A Moynihan · University Of Rochester · R01 · FY2016 · AG
Supplemental Citicoline Administration for Reduction of Lung Injury Efficacy Trial (SCARLET)
$543,218Elliott D Crouser · Ohio State University · U01 · FY2023 · AI
Longitudinal Epidemiology
$543,209Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2023 · AG
The role of Nrf2 in T cell function and influenza
$543,080Cheryl Elizabeth Rockwell · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · ES
Macrophage differentiation and disease outcome in influenza infection
$542,926Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2018 · AI
Macrophage differentiation and disease outcome in influenza infection
$542,926Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2021 · AI
Macrophage differentiation and disease outcome in influenza infection
$542,926Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2020 · AI
Macrophage differentiation and disease outcome in influenza infection
$542,926Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2019 · AI
Armed nanobodies as anti-infectives and anti-tumor agents
$542,900Hao Wu · Boston Children'S Hospital · R01 · FY2024 · AI
Armed nanobodies as anti-infectives and anti-tumor agents
$542,900Hao Wu · Boston Children'S Hospital · R01 · FY2025 · AI
The biology of the nuclear export protein in influenza A virus replication
$542,825Benjamin R. Tenoever · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AI
Studies on RNAi Based Delivery in Vivo
$542,790Mark A Kay · Stanford University · R01 · FY2011 · DK
Seasonal and universal Vaccination in aged populations with pre-existing immunity
$542,726Sang-Moo Kang · Georgia State University · R01 · FY2023 · AI
Seasonal and universal Vaccination in aged populations with pre-existing immunity
$542,726Sang-Moo Kang · Georgia State University · R01 · FY2022 · AI
Seasonal and universal Vaccination in aged populations with pre-existing immunity
$542,726Sang-Moo Kang · Georgia State University · R01 · FY2024 · AI
Seasonal and universal Vaccination in aged populations with pre-existing immunity
$542,726Sang-Moo Kang · Georgia State University · R01 · FY2025 · AI